Skip to main content
Erschienen in: Heart and Vessels 5/2015

01.09.2015 | Original Article

Abnormal aortic arch morphology in Turner syndrome patients is a risk factor for hypertension

verfasst von: Katya De Groote, Daniël Devos, Koen Van Herck, Laurent Demulier, Wesley Buysse, Jean De Schepper, Daniël De Wolf

Erschienen in: Heart and Vessels | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

Hypertension in Turner syndrome (TS) is a multifactorial, highly prevalent and significant problem that warrants timely diagnosis and rigorous treatment. The objective of this study was to investigate the association between abnormal aortic arch morphology and hypertension in adult TS patients. This was a single centre retrospective study in 74 adult TS patients (age 29.41 ± 8.91 years) who underwent a routine cardiac MRI. Patients were assigned to the hypertensive group (N = 31) if blood pressure exceeded 140/90 mmHg and/or if they were treated with antihypertensive medication. Aortic arch morphology was evaluated on MRI images and initially assigned as normal (N = 54) or abnormal (N = 20), based on the curve of the transverse arch and the distance between the left common carotid–left subclavian artery. We additionally used a new more objective method to describe aortic arch abnormality in TS by determination of the relative position of the highest point of the transverse arch (AoHP). Logistic regression analysis showed that hypertension is significantly and independently associated with age, BMI and abnormal arch morphology, with a larger effect size for the new AoHP method than for the classical method. TS patients with hypertension and abnormal arch morphology more often had dilatation of the ascending aorta. There is a significant association between abnormal arch morphology and hypertension in TS patients, independent of age and BMI, and not related to other structural heart disease. We suggest that aortic arch morphology should be included in the risk stratification for hypertension in TS and propose a new quantitative method to express aortic arch morphology.
Literatur
1.
Zurück zum Zitat Stochholm K, Juul S, Juel K, Naeraa RW, Gravholt CH (2006) Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J Clin Endocrinol Metab 91(10):3897–3902CrossRefPubMed Stochholm K, Juul S, Juel K, Naeraa RW, Gravholt CH (2006) Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J Clin Endocrinol Metab 91(10):3897–3902CrossRefPubMed
2.
Zurück zum Zitat Gravholt CH, Landin-Wilhelmsen K, Stochholm K, Hjerrild BE, Ledet T, Djurhuus CB, Sylven L, Baandrup U, Kristensen BO, Christiansen JS (2006) Clinical and epidemiological description of aortic dissection in Turner’s syndrome. Cardiol Young 16(5):430–436CrossRefPubMed Gravholt CH, Landin-Wilhelmsen K, Stochholm K, Hjerrild BE, Ledet T, Djurhuus CB, Sylven L, Baandrup U, Kristensen BO, Christiansen JS (2006) Clinical and epidemiological description of aortic dissection in Turner’s syndrome. Cardiol Young 16(5):430–436CrossRefPubMed
3.
Zurück zum Zitat Lin AE, Silberbach M (2007) Focus on the heart and aorta in Turner syndrome. J Pediatr 150(6):572–574CrossRefPubMed Lin AE, Silberbach M (2007) Focus on the heart and aorta in Turner syndrome. J Pediatr 150(6):572–574CrossRefPubMed
4.
Zurück zum Zitat Schoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA (2008) Mortality in women with turner syndrome in Great Britain: a national cohort study. J Clin Endocrinol Metab 93(12):4735–4742CrossRefPubMed Schoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA (2008) Mortality in women with turner syndrome in Great Britain: a national cohort study. J Clin Endocrinol Metab 93(12):4735–4742CrossRefPubMed
5.
Zurück zum Zitat Gotzsche CO, Krag-Olsen B, Nielsen J, Sorensen KE, Kristensen BO (1994) Prevalence of cardiovascular malformations and association with karyotypes in Turner’s syndrome. Arch Dis Child 71(5):433–436CrossRefPubMedCentralPubMed Gotzsche CO, Krag-Olsen B, Nielsen J, Sorensen KE, Kristensen BO (1994) Prevalence of cardiovascular malformations and association with karyotypes in Turner’s syndrome. Arch Dis Child 71(5):433–436CrossRefPubMedCentralPubMed
6.
Zurück zum Zitat Gravholt CH (2005) Clinical practice in Turner syndrome. Nat Clin Pract Endocrinol Metab 1(1):41–52CrossRefPubMed Gravholt CH (2005) Clinical practice in Turner syndrome. Nat Clin Pract Endocrinol Metab 1(1):41–52CrossRefPubMed
7.
Zurück zum Zitat Ho VB, Bakalov VK, Cooley M, Van PL, Hood MN, Burklow TR, Bondy CA (2004) Major vascular anomalies in Turner syndrome: prevalence and magnetic resonance angiographic features. Circulation 110(12):1694–1700CrossRefPubMed Ho VB, Bakalov VK, Cooley M, Van PL, Hood MN, Burklow TR, Bondy CA (2004) Major vascular anomalies in Turner syndrome: prevalence and magnetic resonance angiographic features. Circulation 110(12):1694–1700CrossRefPubMed
8.
Zurück zum Zitat Mazzanti L, Prandstraller D, Fattori R, Lovato L, Cicognani A, Italian Study Group for Turner Syndrome (2006) Monitoring of congenital heart disease (CHD) and aortic dilatation in Turner syndrome: Italian experience. Int Congr Ser 1298:123–130CrossRef Mazzanti L, Prandstraller D, Fattori R, Lovato L, Cicognani A, Italian Study Group for Turner Syndrome (2006) Monitoring of congenital heart disease (CHD) and aortic dilatation in Turner syndrome: Italian experience. Int Congr Ser 1298:123–130CrossRef
9.
Zurück zum Zitat Elsheikh M, Casadei B, Conway GS, Wass JA (2001) Hypertension is a major risk factor for aortic root dilatation in women with Turner’s syndrome. Clin Endocrinol (Oxf) 54(1):69–73CrossRef Elsheikh M, Casadei B, Conway GS, Wass JA (2001) Hypertension is a major risk factor for aortic root dilatation in women with Turner’s syndrome. Clin Endocrinol (Oxf) 54(1):69–73CrossRef
10.
Zurück zum Zitat Hjerrild BE, Mortensen KH, Sorensen KE, Pedersen EM, Andersen NH, Lundorf E, Hansen KW, Horlyck A, Hager A, Christian JS, Gravholt CH (2010) Thoracic aortopathy in Turner syndrome and the influence of bicuspid aortic valves and blood pressure: a CMR study. J Cardiovasc Magn Reson 12(1):12CrossRefPubMedCentralPubMed Hjerrild BE, Mortensen KH, Sorensen KE, Pedersen EM, Andersen NH, Lundorf E, Hansen KW, Horlyck A, Hager A, Christian JS, Gravholt CH (2010) Thoracic aortopathy in Turner syndrome and the influence of bicuspid aortic valves and blood pressure: a CMR study. J Cardiovasc Magn Reson 12(1):12CrossRefPubMedCentralPubMed
11.
Zurück zum Zitat Bondy CA (2007) Care of girls and women with Turner syndrome: a guideline of the turner syndrome study group. J Clin Endocrinol Metab 92(1):10–25CrossRefPubMed Bondy CA (2007) Care of girls and women with Turner syndrome: a guideline of the turner syndrome study group. J Clin Endocrinol Metab 92(1):10–25CrossRefPubMed
12.
Zurück zum Zitat Joyner MJ, Charkoudian N, Wallin BG (2008) A sympathetic view of the sympathetic nervous system and human blood pressure regulation. Exp Physiol 93(6):715–724CrossRefPubMedCentralPubMed Joyner MJ, Charkoudian N, Wallin BG (2008) A sympathetic view of the sympathetic nervous system and human blood pressure regulation. Exp Physiol 93(6):715–724CrossRefPubMedCentralPubMed
13.
Zurück zum Zitat Gravholt CH, Hansen KW, Erlandsen M, Ebbehoj E, Christiansen JS (2006) Nocturnal hypertension and impaired sympathovagal tone in Turner syndrome. J Hypertens 24(2):353–360CrossRefPubMed Gravholt CH, Hansen KW, Erlandsen M, Ebbehoj E, Christiansen JS (2006) Nocturnal hypertension and impaired sympathovagal tone in Turner syndrome. J Hypertens 24(2):353–360CrossRefPubMed
14.
Zurück zum Zitat Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, Redon J, Dominiczak A, Narkiewicz K, Nilsson PM, Burnier M, Viigimaa M, Ambrosioni E, Caufield M, Coca A, Olsen MH, Schmieder RE, Tsioufis C, van de Borne P, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Clement DL, Coca A, Gillebert TC, Tendera M, Rosei EA, Ambrosioni E, Anker SD, Bauersachs J, Hitij JB, Caulfield M, De Buyzere M, De Geest S, Derumeaux GA, Erdine S, Farsang C, Funck-Brentano C, Gerc V, Germano G, Gielen S, Haller H, Hoes AW, Jordan J, Kahan T, Komajda M, Lovic D, Mahrholdt H, Olsen MH, Ostergren J, Parati G, Perk J, Polonia J, Popescu BA, Reiner Z, Ryden L, Sirenko Y, Stanton A, Struijker-Boudier H, Tsioufis C, van de Borne P, Vlachopoulos C, Volpe M, Wood DA (2013) 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34(28):1925–1938 Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, Redon J, Dominiczak A, Narkiewicz K, Nilsson PM, Burnier M, Viigimaa M, Ambrosioni E, Caufield M, Coca A, Olsen MH, Schmieder RE, Tsioufis C, van de Borne P, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Clement DL, Coca A, Gillebert TC, Tendera M, Rosei EA, Ambrosioni E, Anker SD, Bauersachs J, Hitij JB, Caulfield M, De Buyzere M, De Geest S, Derumeaux GA, Erdine S, Farsang C, Funck-Brentano C, Gerc V, Germano G, Gielen S, Haller H, Hoes AW, Jordan J, Kahan T, Komajda M, Lovic D, Mahrholdt H, Olsen MH, Ostergren J, Parati G, Perk J, Polonia J, Popescu BA, Reiner Z, Ryden L, Sirenko Y, Stanton A, Struijker-Boudier H, Tsioufis C, van de Borne P, Vlachopoulos C, Volpe M, Wood DA (2013) 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34(28):1925–1938
15.
Zurück zum Zitat Zuckerman-Levin N, Zinder O, Greenberg A, Levin M, Jacob G, Hochberg Z (2006) Physiological and catecholamine response to sympathetic stimulation in Turner syndrome. Clin Endocrinol (Oxf) 64(4):410–415CrossRef Zuckerman-Levin N, Zinder O, Greenberg A, Levin M, Jacob G, Hochberg Z (2006) Physiological and catecholamine response to sympathetic stimulation in Turner syndrome. Clin Endocrinol (Oxf) 64(4):410–415CrossRef
16.
Zurück zum Zitat Nathwani NC, Unwin R, Brook CG, Hindmarsh PC (2000) The influence of renal and cardiovascular abnormalities on blood pressure in Turner syndrome 135. Clin Endocrinol (Oxf) 52(3):371–377CrossRef Nathwani NC, Unwin R, Brook CG, Hindmarsh PC (2000) The influence of renal and cardiovascular abnormalities on blood pressure in Turner syndrome 135. Clin Endocrinol (Oxf) 52(3):371–377CrossRef
17.
Zurück zum Zitat Kim HK, Gottliebson W, Hor K, Backeljauw P, Gutmark-Little I, Salisbury SR, Racadio JM, Helton-Skally K, Fleck R (2011) Cardiovascular anomalies in Turner syndrome: spectrum, prevalence, and cardiac MRI findings in a pediatric and young adult population. AJR Am J Roentgenol 196(2):454–460CrossRefPubMed Kim HK, Gottliebson W, Hor K, Backeljauw P, Gutmark-Little I, Salisbury SR, Racadio JM, Helton-Skally K, Fleck R (2011) Cardiovascular anomalies in Turner syndrome: spectrum, prevalence, and cardiac MRI findings in a pediatric and young adult population. AJR Am J Roentgenol 196(2):454–460CrossRefPubMed
18.
Zurück zum Zitat Haycock GB, Schwartz GJ, Wisotsky DH (1978) Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. J Pediatr 93(1):62–66CrossRefPubMed Haycock GB, Schwartz GJ, Wisotsky DH (1978) Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. J Pediatr 93(1):62–66CrossRefPubMed
19.
Zurück zum Zitat Matura LA, Ho VB, Rosing DR, Bondy CA (2007) Aortic dilatation and dissection in Turner syndrome. Circulation 116(15):1663–1670CrossRefPubMed Matura LA, Ho VB, Rosing DR, Bondy CA (2007) Aortic dilatation and dissection in Turner syndrome. Circulation 116(15):1663–1670CrossRefPubMed
20.
Zurück zum Zitat Ou P, Bonnet D, Auriacombe L, Pedroni E, Balleux F, Sidi D, Mousseaux E (2004) Late systemic hypertension and aortic arch geometry after successful repair of coarctation of the aorta. Eur Heart J 25(20):1853–1859CrossRefPubMed Ou P, Bonnet D, Auriacombe L, Pedroni E, Balleux F, Sidi D, Mousseaux E (2004) Late systemic hypertension and aortic arch geometry after successful repair of coarctation of the aorta. Eur Heart J 25(20):1853–1859CrossRefPubMed
21.
Zurück zum Zitat Baguet JP, Douchin S, Pierre H, Rossignol AM, Bost M, Mallion JM (2005) Structural and functional abnormalities of large arteries in the Turner syndrome. Heart 91(11):1442–1446CrossRefPubMedCentralPubMed Baguet JP, Douchin S, Pierre H, Rossignol AM, Bost M, Mallion JM (2005) Structural and functional abnormalities of large arteries in the Turner syndrome. Heart 91(11):1442–1446CrossRefPubMedCentralPubMed
22.
Zurück zum Zitat Gomez D, Al Haj ZA, Borges LF, Philippe M, Gutierrez PS, Jondeau G, Michel JB, Vranckx R (2009) Syndromic and non-syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathway. J Pathol 218(1):131–142CrossRefPubMed Gomez D, Al Haj ZA, Borges LF, Philippe M, Gutierrez PS, Jondeau G, Michel JB, Vranckx R (2009) Syndromic and non-syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathway. J Pathol 218(1):131–142CrossRefPubMed
23.
Zurück zum Zitat Lin AE, Lippe BM, Geffner ME, Gomes A, Lois JF, Barton CW, Rosenthal A, Friedman WF (1986) Aortic dilation, dissection, and rupture in patients with Turner syndrome. J Pediatr 109(5):820–826CrossRefPubMed Lin AE, Lippe BM, Geffner ME, Gomes A, Lois JF, Barton CW, Rosenthal A, Friedman WF (1986) Aortic dilation, dissection, and rupture in patients with Turner syndrome. J Pediatr 109(5):820–826CrossRefPubMed
24.
Zurück zum Zitat Marque V, Kieffer P, Gayraud B, Lartaud-Idjouadiene I, Ramirez F, Atkinson J (2001) Aortic wall mechanics and composition in a transgenic mouse model of Marfan syndrome. Arterioscler Thromb Vasc Biol 21(7):1184–1189CrossRefPubMed Marque V, Kieffer P, Gayraud B, Lartaud-Idjouadiene I, Ramirez F, Atkinson J (2001) Aortic wall mechanics and composition in a transgenic mouse model of Marfan syndrome. Arterioscler Thromb Vasc Biol 21(7):1184–1189CrossRefPubMed
25.
Zurück zum Zitat Pezzini A, Del Zotto E, Giossi A, Volonghi I, Costa P, Padovani A (2012) Transforming growth factor beta signaling perturbation in the Loeys-Dietz syndrome. Curr Med Chem 19(3):454–460CrossRefPubMed Pezzini A, Del Zotto E, Giossi A, Volonghi I, Costa P, Padovani A (2012) Transforming growth factor beta signaling perturbation in the Loeys-Dietz syndrome. Curr Med Chem 19(3):454–460CrossRefPubMed
26.
Zurück zum Zitat Takata M, Amiya E, Watanabe M, Omori K, Imai Y, Fujita D, Nishimura H, Kato M, Morota T, Nawata K, Ozeki A, Watanabe A, Kawarasaki S, Hosoya Y, Nakao T, Maemura K, Nagai R, Hirata Y, Komuro I (2013) Impairment of flow-mediated dilation correlates with aortic dilation in patients with Marfan syndrome. Heart Vessels. doi:10.1007/s00380-013-0393-3 Takata M, Amiya E, Watanabe M, Omori K, Imai Y, Fujita D, Nishimura H, Kato M, Morota T, Nawata K, Ozeki A, Watanabe A, Kawarasaki S, Hosoya Y, Nakao T, Maemura K, Nagai R, Hirata Y, Komuro I (2013) Impairment of flow-mediated dilation correlates with aortic dilation in patients with Marfan syndrome. Heart Vessels. doi:10.​1007/​s00380-013-0393-3
27.
Zurück zum Zitat Chrysohoou C, Skoumas J, Oikonomou E, Tsiachris D, Metaxa V, Lagoudakou S, Felekos J, Masoura C, Athanassopoulou S, Kosyfa H, Pitsavos C, Stefanadis C (2013) Aortic artery distensibility shows inverse correlation with heart rate variability in elderly non-hypertensive, cardiovascular disease-free individuals: the Ikaria Study. Heart Vessels 28(4):467–472CrossRefPubMed Chrysohoou C, Skoumas J, Oikonomou E, Tsiachris D, Metaxa V, Lagoudakou S, Felekos J, Masoura C, Athanassopoulou S, Kosyfa H, Pitsavos C, Stefanadis C (2013) Aortic artery distensibility shows inverse correlation with heart rate variability in elderly non-hypertensive, cardiovascular disease-free individuals: the Ikaria Study. Heart Vessels 28(4):467–472CrossRefPubMed
28.
Zurück zum Zitat Gittenberger-de Groot AC, Bartelings MM, Poelmann RE, Haak MC, Jongbloed MR (2013) Embryology of the heart and its impact on understanding fetal and neonatal heart disease. Semin Fetal Neonatal Med 18(5):237–244CrossRefPubMed Gittenberger-de Groot AC, Bartelings MM, Poelmann RE, Haak MC, Jongbloed MR (2013) Embryology of the heart and its impact on understanding fetal and neonatal heart disease. Semin Fetal Neonatal Med 18(5):237–244CrossRefPubMed
Metadaten
Titel
Abnormal aortic arch morphology in Turner syndrome patients is a risk factor for hypertension
verfasst von
Katya De Groote
Daniël Devos
Koen Van Herck
Laurent Demulier
Wesley Buysse
Jean De Schepper
Daniël De Wolf
Publikationsdatum
01.09.2015
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 5/2015
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-014-0529-0

Weitere Artikel der Ausgabe 5/2015

Heart and Vessels 5/2015 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.